Pfizer's gene therapy for a muscle-wasting disorder misses main goal of late-stage study

Retrieved on: 2024-06-12 21:25:53

Tags for this article:

Click the tags to see associated articles and topics

Pfizer's gene therapy for a muscle-wasting disorder misses main goal of late-stage study. View article details on hiswai:

Excerpt

(Reuters) - Pfizer said on Wednesday its experimental gene therapy for a type of muscle-wasting disorder did not meet the main goal of a ...

Article found on: wtvbam.com